sFlt-1, a potential antagonist for exogenous VEGF.
Belgore
F M
FM
Blann
A D
AD
Lip
G Y
GY
D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors* / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008222:Lymphokines / Q000037:antagonists & inhibitors* / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000378:metabolism; D010865:Pilot Projects; D011518:Proto-Oncogene Proteins / Q000097:blood / Q000494:pharmacology*; D020794:Receptor Protein-Tyrosine Kinases / Q000097:blood / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A; D040281:Vascular Endothelial Growth Factor Receptor-1; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D011518:Proto-Oncogene Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D020794:Receptor Protein-Tyrosine Kinases; D040281:Vascular Endothelial Growth Factor Receptor-1